The FDA Removed the Black Box Warning on Hormone Therapy. Hereโ€™s What That Means for You

Follow on your favorite platform

In 2002, a single study made front pages around the world, and millions of women flushed their hormone prescriptions within months. The study was the Women's Health Initiative, the headline said hormones cause breast cancer, and as I say in this week's episode: the headline got out before the science did.

On November 10, 2025, the FDA removed the black box warning (its most serious caution) from menopausal hormone therapy. If you're wondering how we got from there to here, and what it means for your own care, this is the plain-language version.


This week on Endocrine Matters, I walk through the whole story. Watch the full episode on my channel.


What The WHI Actually Studied

The panic came from a study of the wrong population on the wrong medications. The WHI enrolled women with an average age in their 60s, many a full decade past menopause, and gave them oral estrogen with a synthetic progestin.

Today's standard looks different: transdermal estrogen (a patch or gel) and body-identical progesterone. The study's scariest numbers were also presented as relative risks, which make small absolute changes sound enormous in a headline.

And here is the finding that never made the front page: in the arm of the study where women took estrogen alone, breast cancer risk did not go up. It was slightly lower.


What The FDA Changed In November 2025

The black box warning had sat on hormone therapy for two decades. On November 10, 2025, the FDA removed it. The warnings about heart disease, breast cancer, and dementia came off. The instruction to use the "lowest dose for the shortest time" came off with them.

What the evidence supports instead is a timing principle: starting hormone therapy within about 10 years of menopause, or before age 60, is the sweet spot where benefits generally outweigh risks for healthy women.


What Stays On The Label, And Why It Should

One warning remains, and it's doing its job: taking systemic estrogen alone when you have a uterus raises the risk of uterine cancer.

That is precisely why progesterone is prescribed alongside estrogen for anyone with a uterus. If your clinician pairs them, that's not caution theater. That's the remaining warning working as intended.


Who Hormone Therapy Isn't For

Honest medicine also means saying who this isn't for. Certain breast cancers and a history of blood clots or stroke are real contraindications.

Hormone therapy is an option for most women in the right window (most, not all), and sorting which takes an individualized assessment, not a blanket answer in either direction.

(For the record: Public Citizen objected to the FDA's removal. Their core concern, that risk varies person to person, is an argument for exactly that individualized assessment, which is what menopause-trained clinicians do.)


If Your Doctor Is Still Saying No With A 2002 Explanation

Some doctors have kept pace with two decades of evidence. Some haven't; as I put it in the episode, it's still 2002 in their head.

If your doctor is scared to prescribe hormones, you don't need to convince your doctor. You need a new doctor: specifically, a Menopause Society Certified Practitioner, which you can search for free at menopause.org. (I am one.)

And please stop choosing this doctor by insurance network alone. That's like choosing a hairstylist based only on who has a parking spot. Out-of-network care doesn't have to break the bank. Direct care practices like mine post transparent prices, and many patients self-submit for reimbursement.


The Bottom Line

The 2002 headline was about the wrong women on the wrong medications, and in 2025 the FDA finally said so in its strongest regulatory language. Hormone therapy has real candidates and real contraindications, and you deserve a clinician who can tell you which you are, not one still quoting a headline.

If you want that conversation with time actually built in, that's what Complete Medicine is for. Learn more here. Start with this week's episode, then read the perimenopause labs guide next.


๐Ÿ“ Still have questions?
๐Ÿ’ฌ Contact us and we'll be happy to help!
๐Ÿ’Œ Or join our newsletter to stay informed: Sign up here


FAQs

Is HRT safe now that the FDA removed the black box warning? For most healthy women who start within about 10 years of menopause or before age 60, benefits generally outweigh risks. Real contraindications remain (certain breast cancers and a history of clots or stroke), so the answer is individualized, not universal.

What did the WHI study actually find? It studied women averaging their 60s, on oral estrogen plus synthetic progestin. The alarming headline numbers were relative risks. In the estrogen-alone arm, breast cancer risk did not increase. It was slightly lower.

What exactly did the FDA remove in 2025? On November 10, 2025, the FDA removed the boxed warnings about heart disease, breast cancer, and dementia from menopausal hormone therapy, along with the "lowest dose for the shortest time" instruction. The uterine cancer warning for estrogen alone with a uterus remains.

Why do I need progesterone with estrogen? If you have a uterus, estrogen alone raises uterine cancer risk. Progesterone is added specifically to protect the uterine lining.

Who should not take hormone therapy? Women with certain breast cancers or a history of blood clots or stroke, among other contraindications. A menopause-trained clinician can review your full history.

How do I find a menopause specialist? Search the free Menopause Society practitioner finder at menopause.org, and verify board certification at certificationmatters.org before reading reviews.

Arti Thangudu, MD

CEO/Founder HeyHealthy & Complete Medicine

Triple Board Certified in Endocrinology/Diabetes/Metabolism, Internal Medicine, Lifestyle Medicine

Previous
Previous

Can You Take a GLP-1 at a Normal Weight? What the New Pills Mean for South Asians

Next
Next

Why Is My Doctor Always Rushed? The 7-Minute Visit, Explained